Health Rhythm Biosciences Launches Enhanced Colorectal Cancer Risk Test Rhythm Biosciences Ltd has officially launched its enhanced geneType TM Colorectal Cancer (CRC) Risk Assessment clinical test, a notable development aimed at improving the... Editorial14 January, 2026